Logo

Accelerate Diagnostics: Hany Massarany

Mar 08, 2023

Accelerate Diagnostics has appointed Hany Massarany as chairman of the board, effective Feb. 22. He replaces John Patience, who will remain on the board and had been chairman for 10 years. Massarany was president and CEO of GenMark Diagnostics, and prior to that he was president of Ventana Medical Systems, now part of Roche, and head of Roche Tissue Diagnostics. He also served as COO at Ventana. Massarany also previously held executive management positions at Bayer Diagnostics and Chiron Diagnostics.

Breaking News
The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.